StreetInsider.com News Articles

Aurora Spine Announces Publication of REFINE Study's 12-Month Results in the International Journal of Spine Surgery

Thu, 22 Oct 2026 17:56:00 -0400

Peer-reviewed publication adds prospective, multicenter clinical evidence for the ZIP MIS Interlaminar Fusion System

Carlsbad, California--(Newsfile Corp. - October 22, 2026) - Aurora Spine Corporation (TSXV: ASG) (OTCQB: ASAPF) ("Aurora Spine" or the "Company"), a developer and manufacturer of minimally invasive spinal implants and interventional pain management technologies, today announced the publication of the REFINE study's 12-month results in the International Journal of Spine Surgery.

Published online on October 9, 2026, the article reports on a prospective, observational, open-label, nonrandomized, multicenter study evaluating Aurora Spine's ZIP™ MIS Interlaminar Fusion System. The study examined patients with symptomatic neurogenic claudication associated with lumbar spinal stenosis in the

Aurora Spine Announces Publication of REFINE Study's 12-Month Results in the International Journal of Spine Surgery

Thu, 22 Oct 2026 17:56:00 -0400

Peer-reviewed publication adds prospective, multicenter clinical evidence for the ZIP MIS Interlaminar Fusion System

Aurora Spine Announces Publication of REFINE Study's 12-Month Results in the International Journal of Spine Surgery

Thu, 22 Oct 2026 17:56:00 -0400

Peer-reviewed publication adds prospective, multicenter clinical evidence for the ZIP MIS Interlaminar Fusion System

Aurora Spine Announces Publication of REFINE Study's 12-Month Results in the International Journal of Spine Surgery

Thu, 22 Oct 2026 17:56:00 -0400

Peer-reviewed publication adds prospective, multicenter clinical evidence for the ZIP MIS Interlaminar Fusion System

Aurora Spine Corporation Announces Amendment to Loan from Insider

Tue, 29 Sep 2026 18:53:00 -0400

Carlsbad, California--(Newsfile Corp. - September 29, 2026) - Aurora Spine Corporation (TSXV: ASG) ("Aurora Spine" or the "Company") announced today that an insider of the Company has agreed to increase the principal amount available under an existing loan with the Company (the "Loan") by US$200,000. As a result of this increase, the total principal amount owing by the Company to the insider is US$2.4 million (the "Principal Amount"). The Company intends to use the Loan proceeds for general corporate purposes.

The Loan is evidenced by a promissory note (the "Note") bearing interest at 4.5% per annum. The Principal Amount together with interest

Aurora Spine Corporation Announces Amendment to Loan from Insider

Tue, 29 Sep 2026 18:53:00 -0400

The Loan is evidenced by a promissory note (the "Note") bearing interest at 4.5% per annum. The Principal Amount together with interest

Aurora Spine Corporation Announces Amendment to Loan from Insider

Tue, 29 Sep 2026 18:53:00 -0400

The Loan is evidenced by a promissory note (the "Note") bearing interest at 4.5% per annum. The Principal Amount together with interest

Aurora Spine Corporation Announces Amendment to Loan from Insider

Tue, 29 Sep 2026 18:53:00 -0400

The Loan is evidenced by a promissory note (the "Note") bearing interest at 4.5% per annum. The Principal Amount together with interest

Aurora Spine Corporation Announces Second Quarter FY26 Financial Results

Thu, 27 Aug 2026 07:00:00 -0400

- Company to host conference call Today, August 27th at 11am ET/8am PT -

NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE SERVICES

Carlsbad, California--(Newsfile Corp. - August 27, 2026) - Aurora Spine Corporation (TSXV: ASG) (OTCQB: ASAPF) ("Aurora Spine" or the "Company"), a leader in the development of groundbreaking medical devices for spinal surgery, today announced its financial results for the second quarter of fiscal year 2026 ended June 30, 2026.

All figures are in U.S. dollars.

Business Highlights

New Commercial Alliance - Announced Strategic Commercial Alliance with CornerLoc to expand minimally invasive spine and

Aurora Spine Corporation Announces Second Quarter FY26 Financial Results

Thu, 27 Aug 2026 07:00:00 -0400

- Company to host conference call Today, August 27th at 11am ET/8am PT -

NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE SERVICES

All figures are in U.S. dollars.

Business Highlights

New Commercial Alliance - Announced Strategic Commercial Alliance with CornerLoc to expand minimally invasive spine and

Aurora Spine settles patent dispute, secures $600K insider loan

Fri, 14 Aug 2026 17:02:14 -0400

Aurora Spine Corporation (TSXV: ASG) (OTCQB: ASAPF) announced it has reached a settlement in an arbitration dispute and entered into a new patent license agreement related to its SiLO TFX Transfixing SI Joint System, according to a press release dated August 14, 2026.

The Carlsbad, California-based company signed a new non-exclusive license to US patent #9,451,986 with SILIF Corporation of New York. The four-year license, beginning August 11, 2026, replaces a prior agreement and resolves a disagreement over royalty payment calculations.

As part of the settlement, Aurora Spine will pay SILIF $283,000 in cash. In return, SILIF will return 2,700,000 shares to

Aurora Spine Announces Settlement of Arbitration, New Patent License Agreement for SI Joint Product and Increase in Funding from Insider

Fri, 14 Aug 2026 17:00:00 -0400

Carlsbad, California--(Newsfile Corp. - August 14, 2026) - Aurora Spine Corporation (TSXV: ASG) ("Aurora Spine" or the "Company") announced today that it has entered into a new non-exclusive license to US patent #9,451,986 titled "Percutaneous sacroiliac joint implant and method for surgically inserting and securing the implant into the sacroiliac joint" in an agreement with SILIF Corporation of New York, New York ("SILIF"). The new patent license replaces a previous version that the Company utilized in developing its market leading SiLO TFX Transfixing SI Joint System.

The new license is for a four (4) year term beginning August 11, 2026, and resolves a

Aurora Spine Announces Settlement of Arbitration, New Patent License Agreement for SI Joint Product and Increase in Funding from Insider

Fri, 14 Aug 2026 17:00:00 -0400

The new license is for a four (4) year term beginning August 11, 2026, and resolves a

Aurora Spine and CornerLoc Announce Strategic Commercial Alliance to Expand Minimally Invasive Spine and SI Joint Solutions Nationwide

Thu, 16 Jul 2026 06:50:00 -0400

Carlsbad, California and Tulsa, Oklahoma--(Newsfile Corp. - July 16, 2026) - Aurora Spine Corporation ("Aurora Spine" or the "Company") (TSXV: ASG) (OTCQB: ASAPF), a leader in the development of groundbreaking medical devices for spinal surgery and Foundation Fusion Solutions, LLC dba CornerLoc, founded on one idea: provide patients with an intelligent and lasting solution for SI joint fusion, today announced the formation of a Strategic Commercial Alliance designed to expand physician access to innovative minimally invasive spine and sacroiliac (SI) joint technologies across the United States.

The alliance brings together Aurora Spine's comprehensive portfolio of minimally invasive spine technologies, public company

Aurora Spine and CornerLoc Announce Strategic Commercial Alliance to Expand Minimally Invasive Spine and SI Joint Solutions Nationwide

Thu, 16 Jul 2026 06:50:00 -0400

The alliance brings together Aurora Spine's comprehensive portfolio of minimally invasive spine technologies, public company

Aurora Spine Corporation Schedules Release of First Quarter Fiscal 2026 Financial Results